EMA Authorised: Voxzogo (vosoritide) — BioMarin International Limited

View source ↗

Summary

EMA authorises Voxzogo (vosoritide) for achondroplasia, granted orphan medicine status to BioMarin International Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• VOXZOGO (VOSORITIDE)

Snippet

Status: Authorised. Therapeutic area: Achondroplasia. MAH: BioMarin International Limited. Decision date: 07/04/2026. Orphan medicine